However, in our study consistent lower LDL and TC in CAD patients may be the effect of statins or lipid lowering drugs, we found no significant difference in the expression levels of ESM-1 between patients with oral lipid-lowering drugs and those without oral lipid-lowering drugs. The gene discussed is ESM1; the disease is coronary artery disorder.